Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Short-term Investments (2024)

Historic Short-term Investments for Precision Biosciences (DTIL) over the last 1 years, with Q4 2024 value amounting to $413000.0.

  • Precision Biosciences' Short-term Investments changed N/A to $413000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $413000.0, marking a year-over-year change of. This contributed to the annual value of $413000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q4 2024, Precision Biosciences' Short-term Investments is $413000.0.
  • Precision Biosciences' 5-year Short-term Investments high stood at $2.4 million for Q3 2024, and its period low was $413000.0 during Q4 2024.